OpenAlex
PricingAboutJobs
Log inGet started
Work

Emerging drugs for major depressive disorder

HTML

Year: 2012
Type: review
Source: Expert Opinion on Emerging Drugs
DOI: 10.1517/14728214.2012.660146
Authors: Kevin Ryan Connolly, Michael E Thase
Institutions: Philadelphia VA Medical Center, University of Pennsylvania, University of Pittsburgh Medical Center
Language: English

Topic: Treatment of Major Depression
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: major depressive disorder, antidepressant drug development, desvenlafaxine, vilazodone, aripiprazole, quetiapine, augmentation therapy, ketamine, glutamatergic neurotransmission, monoamine neurotransmission, cholinergic neurotransmission, sigma receptors, neurokinin receptors
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2159835986
FWCI: 1.615
Cites: 104
Cited by: 106
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security